PMID- 11158965 OWN - NLM STAT- MEDLINE DCOM- 20010322 LR - 20200930 IS - 0363-6135 (Print) IS - 0363-6135 (Linking) VI - 280 IP - 2 DP - 2001 Feb TI - Involvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats. PG - H668-73 AB - We investigated the possible contribution of inducible nitric oxide synthase (iNOS) to postischemic heart dysfunction and injuries in stroke-prone spontaneously hypertensive rats (SHRSP). SHRSP, 13-14 wk of age, had significantly higher systolic blood pressure and greater heart weight than age-matched Wistar-Kyoto rats (WKY). Permanent occlusion of the left anterior descending coronary artery (LAD) caused significant and long-lasting increases in the activity and mRNA expression of myocardial iNOS in SHRSP compared with WKY. However, there was no significant difference in the LAD occlusion-induced expression of interleukin-1beta mRNA between SHRSP and WKY. Hemodynamic deterioration and myocardial fibrosis were also observed in SHRSP at 4 wk after LAD occlusion. Continuous administration of 2-amino-5,6-dihydro-6-methyl-4H-1,2-thiazin (AMT) completely blocked the LAD occlusion-induced increase in the myocardial iNOS activity of SHRSP. Moreover, postischemic heart dysfunction and injuries were also significantly ameliorated by 2-amino-5,6-dihydro-6-methyl-4H-1,2-thiazin (AMT). These results suggest that the increased activity of myocardial iNOS plays a pivotal role in the development of postischemic cardiac dysfunction and injuries in SHRSP with the hypertensive and hypertrophic heart. FAU - Abe, K AU - Abe K AD - Department of Drug Safety Evaluation, Developmental Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka 561-0825, Japan. kohji.abe@shionogi.co.jp FAU - Tokumura, M AU - Tokumura M FAU - Ito, T AU - Ito T FAU - Murai, T AU - Murai T FAU - Takashima, A AU - Takashima A FAU - Ibii, N AU - Ibii N LA - eng PT - Journal Article PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine) RN - 0 (Enzyme Inhibitors) RN - 0 (Interleukin-1) RN - 0 (Lipopolysaccharides) RN - 0 (RNA, Messenger) RN - 0 (Thiazines) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.13.39 (Nos2 protein, rat) SB - IM MH - Animals MH - Cardiomegaly/metabolism/pathology MH - Coronary Circulation MH - Coronary Disease/metabolism/pathology MH - Enzyme Inhibitors/pharmacology MH - Fetal Blood MH - Gene Expression Regulation, Enzymologic/drug effects MH - Interleukin-1/genetics MH - Lipopolysaccharides/pharmacology MH - Male MH - Myocardial Ischemia/*metabolism/pathology MH - Myocardium/*enzymology/pathology MH - Nitric Oxide Synthase/antagonists & inhibitors/*genetics/*metabolism MH - Nitric Oxide Synthase Type II MH - Organ Size MH - RNA, Messenger/analysis MH - Rats MH - Rats, Inbred SHR MH - Rats, Inbred WKY MH - Stroke/metabolism MH - Thiazines/pharmacology EDAT- 2001/02/13 11:00 MHDA- 2001/03/27 10:01 CRDT- 2001/02/13 11:00 PHST- 2001/02/13 11:00 [pubmed] PHST- 2001/03/27 10:01 [medline] PHST- 2001/02/13 11:00 [entrez] AID - 10.1152/ajpheart.2001.280.2.H668 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H668-73. doi: 10.1152/ajpheart.2001.280.2.H668.